4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-014944
Chief Executive Officer sold 7,800 shares at an average $36.14 ($281,891)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2019-02-27 | Sale | −200 | $35.22 | $7,044 | 343,137 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-02-27 | Sale | −3,700 | $36.20 | $133,940 | 339,437 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-02-28 | Sale | −3,900 | $36.13 | $140,907 | 335,537 | I |
| Open-market sales · 7,800 sh · avg $36.14 · $281,891 | |||||||
Loading xslF345X03/doc4.xml…